Skip to content

Study for intestinal flora distribution of Graves' orbitopathy

Study for intestinal flora distribution of Graves' orbitopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027383
Enrollment
Unknown
Registered
2019-11-11
Start date
2019-03-25
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves' orbitopathy

Interventions

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Healthy control group (HC group): people over 18 years old and under 70 years old with healthy physical examination; 2. Graves' disease group (GD group): the age was over 18 years old and less than 70 years old. The thyroid function was in line with: free triiodine-methylamine (FT3), free thyroxine (FT4), TRAb higher than the normal high limit, and thyrotropin (TSH) lower than the normal low limit. No anti-armour treatment for 6 months.Except GO patients; 3. Thyroid related ophthalmopathy group (GO group): aged over 18 years old, younger than 70 years old, without hormone treatment, meeting the diagnostic criteria of Bartly.

Exclusion criteria

Exclusion criteria: 1. Suffer from intestinal diseases, such as inflammatory bowel disease, irritable bowel syndrome, etc.; 2. Suffering from ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis and other autoimmune diseases; 3. Diabetes, obesity, high blood pressure; 4. Have a malignant tumor; 5. Suffering from mental disorders, such as schizophrenia, depression, autism, etc.; 6. Used glucocorticoid or immunosuppressant within 6 months; 7. Antibiotics in the last 1 month; 8. Pregnancy or lactation; 9. Had a history of gastrointestinal surgery or other types of surgery for nearly half a year.

Design outcomes

Primary

MeasureTime frame
gut microbiota;Immune-related factor;Orbit MR;Free triiodothyronine;Free thyroxine;Serum thyrotropin;Thyrotropin receptor antibody;Thyroglobulin antibody;Thyroid peroxidase antibody;CAS score;

Countries

China

Contacts

Public ContactYongquan Shi

Shanghai Changzheng Hospital

young.stone@163.com+86 021-81885375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026